Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GABA Schweiz
Therwil, Basel-Landschaft, Switzerlandgaba.ch ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
GABA is a leading Swiss oral care company specializing in the development and commercialization of scientifically-backed dental hygiene products. Originally established as the Goldene Apotheke Basel, the company is renowned for introducing amine fluoride technology, which is a cornerstone of its flagship brand, Elmex. Its portfolio also includes Meridol, focused on gum health, and Aronal, designed for morning oral protection. Since being acquired by Colgate-Palmolive in 2004, GABA has continued to serve as a center of excellence for oral health, maintaining strong ties with dental professionals and pharmacies across Europe.
- Therapeutic areas
- Infectious DiseasesOtherGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on GABA Schweiz.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GABA Schweiz.